Home
Aleva Neurotherapeutics SA

Aleva Neurotherapeutics SA Market Share Analysis for June 2026

Industry: N/A

Domainaleva-neuro.com

Year Founded2008

Employees51 - 200

Annual Revenue$2M - $5M

Aleva Neurotherapeutics SA

Aleva Neurotherapeutics SA (including company regionals)

aleva-neuro.com

See more website traffic and engagement information

Aleva Neurotherapeutics SA Revenue up to June 2026 is 2M - 5M

revenue generated by Aleva Neurotherapeutics SA top domains

Aleva Neurotherapeutics SA top domains revenue over 3 years

Revenue for Aleva Neurotherapeutics SA top domains

aleva-neuro.com2M - 5M

See more with Sales Intelligence

Total visits to Aleva Neurotherapeutics SA's top domains

Understand Aleva Neurotherapeutics SA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aleva-neuro.com386

See more with Sales Intelligence

Avg. visit duration in Aleva Neurotherapeutics SA's top domains

Analyze Aleva Neurotherapeutics SA engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Aleva Neurotherapeutics SA's top domains

See how Aleva Neurotherapeutics SA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aleva-neuro.com1.02

See more with Sales Intelligence

Aleva Neurotherapeutics SA top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Aleva Neurotherapeutics SA

These are the website technologies, by industry, used by Aleva Neurotherapeutics SA top domains

Payment & Currencies (4)

Cart Functionality

Content Management System (3)

WordPress

Advertising (2)

PubMatic

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from Aleva Neurotherapeutics SA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAleva Neurotherapeutics SA launches Directional mode of Deep Brain Stimulation to Neuromodulation treatments.Aleva introduced the Directional mode of Deep Brain Stimulation to Neuromodulation treatments, and its clinically proven technology has set the industry standard for directional leads.

NewsAleva Neurotherapeutics SA is developing novel brain stimulation products.Based on its proprietary technology, Aleva has developed novel brain stimulation products with different properties.

NewsAleva Neurotherapeutics SA receives financing of $8M in Serious E financing round.Furthermore, Aleva Neurotherapeutics has also raised $8m in a Serious E financing round, joined by the company’s existing, as well as undisclosed private, investors.